Drug Trio Aims at Two Cell Types in Pancreatic Cancer

Newsfeed Image, Light Gray Text On Dark Gray Background
A three-drug combination can simultaneously target pancreatic cancer cells, as well as the other harmful, inflammatory cells within tumors, according to new research.

The research may define a more personalized approach to treating pancreatic cancer. Ultimately, physicians could use information from the pancreas tumor biopsy about volume and predominance of cancer cells and non-cancerous inflammatory cells that affect the immune system, and then plan the best treatment. Read more . . .